Literature DB >> 1371102

An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.

R Guntern1, C Bouras, P R Hof, P G Vallet.   

Abstract

Large differences are usually observed when standard staining methods for a number of pathological lesions in neurodegenerative disorders are compared. With the modified thioflavine S method presented here (easy and cheap to perform), the morphological appearance of the stained neurofibrillary tangles (NFT) and senile plaques (SP) is greatly improved. Furthermore, the intense contrast between stained lesions and background obtained with this technique permits an accurate automatic quantification of NFT and SP using a computer-assisted image analysis system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371102     DOI: 10.1007/bf01923594

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  13 in total

1.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.

Authors:  D A Lewis; M J Campbell; R D Terry; J H Morrison
Journal:  J Neurosci       Date:  1987-06       Impact factor: 6.167

2.  A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles.

Authors:  T Yamamoto; A Hirano
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Jan-Feb       Impact factor: 8.090

3.  Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method.

Authors:  C Duyckaerts; J P Brion; J J Hauw; J Flament-Durand
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Comparison of four staining methods on the detection of neuritic plaques.

Authors:  H M Wisniewski; G Y Wen; K S Kim
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Harigaya
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

7.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.

Authors:  P R Hof; J H Morrison
Journal:  J Comp Neurol       Date:  1990-11-01       Impact factor: 3.215

8.  Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.

Authors:  J Rogers; J H Morrison
Journal:  J Neurosci       Date:  1985-10       Impact factor: 6.167

9.  Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway.

Authors:  P R Hof; C Bouras; J Constantinidis; J H Morrison
Journal:  Brain Res       Date:  1989-07-31       Impact factor: 3.252

10.  An improved immunohistostaining procedure for peptides in human brain.

Authors:  R Guntern; P G Vallet; C Bouras; J Constantinidis
Journal:  Experientia       Date:  1989-02-15
View more
  46 in total

1.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

Authors:  V Heiser; E Scherzinger; A Boeddrich; E Nordhoff; R Lurz; N Schugardt; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Authors:  Srikant Rangaraju; Marla Gearing; Lee-Way Jin; Allan Levey
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition.

Authors:  Daniel S Heffron; Gary E Landreth; Ivy S Samuels; James W Mandell
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

4.  Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections.

Authors:  A Rosenwald; E Reusche; K Ogomori; H M Teichert
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.

Authors:  Robert Wykes; Abigail Kalmbach; Marina Eliava; Jack Waters
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

6.  Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Brain Pathol       Date:  2011-09-12       Impact factor: 6.508

7.  Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.

Authors:  Karen A Lewis; Yang Su; Olina Jou; Caroline Ritchie; Chan Foong; Linda S Hynan; Charles L White; Philip J Thomas; Kimmo J Hatanpaa
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

Review 8.  The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation.

Authors:  William E Klunk; Chester A Mathis
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

9.  Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.

Authors:  Tatiana Melnikova; Susan Fromholt; HyunSu Kim; Deidre Lee; Guilian Xu; Ashleigh Price; Brenda D Moore; Todd E Golde; Kevin M Felsenstein; Alena Savonenko; David R Borchelt
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

10.  Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.

Authors:  F M LaFerla; C K Hall; L Ngo; G Jay
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.